Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature
Authors:
Open Access
- 18 August 2020
- journal article
- review article
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 45 (6) , 1253-1263
Abstract
What is known and objective Acute kidney injury is a devastating consequence observed with antibiotic therapy. The objective of this review was to summarize available data regarding the rates of acute kidney injury with vancomycin plus piperacillin/tazobactam compared to other beta‐lactam combinations. Methods A PubMed search from 2011 to May 2020 was conducted using the following search terms: vancomycin AND piperacillin/tazobactam AND acute kidney injury. Additional references were identified from a review of citations. Articles evaluating exclusively paediatric patients and articles evaluating vancomycin monotherapy as the comparator group were excluded. Case reports and case series were also excluded. Results and discussion There were 18 studies included. Ten studies adjusted for potential confounders of acute kidney injury. Fourteen retrospective studies, one prospective study and three meta‐analyses found the combination of vancomycin/piperacillin/tazobactam to be associated with a higher rate of acute kidney injury than the comparator group(s). What is new and conclusion Although there are data to support that the combination of vancomycin plus piperacillin‐tazobactam increases the risk of acute kidney, much of the data come from small retrospective studies with variable adjustment for confounders. Furthermore, study heterogeneity on inclusion criteria and evaluation of long‐term outcomes should be cautiously interpreted. Finally, additional data suggest that the risk of acute kidney injury seems to be minimized with shorter courses of therapy. Without prospective studies available, antimicrobial stewardship efforts should continue to target reducing broad‐spectrum regimens, often limiting the need for long‐term vancomycin/piperacillin/tazobactam combination.Keywords
This publication has 25 references indexed in Scilit:
- Is the Combination of Piperacillin‐Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta‐analysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and CefepimeClinical Infectious Diseases, 2016
- Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and VancomycinJournal of Pharmacy Practice, 2016
- Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipAntimicrobial Agents and Chemotherapy, 2016
- Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin‐Tazobactam or Cefepime: A Retrospective Cohort StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with cefepimeClinical Microbiology and Infection, 2014
- Comparison of the Incidence of Vancomycin‐Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin‐TazobactamPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin‐Tazobactam or CefepimePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot InfectionsaClinical Infectious Diseases, 2012
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005